Advancing Cell + Gene Therapies for Cancer

Advancing Cell + Gene Therapies for Cancer is organized by American Society of Gene & Cell Therapy (ASGCT) and will be held from Oct 15 - 16, 2025 at Philadelphia Marriott Downtown, Philadelphia, Pennsylvania, United States of America.

Description:
This 1.5-day event will bring together leading researchers and clinicians to engage with pioneering science and shape the future of cell and gene therapies in cancer. Through a series of focused scientific sessions, the program will explore innovative technologies driving next-generation oncolytic virus and cell therapy platforms, alongside emerging insights into their mechanisms of action, therapeutic potential, and synergies. Dedicated sessions will address barriers such as tumor heterogeneity, off-target effects, delivery limitations, and interactions with the tumor microenvironment—challenges that continue to limit efficacy in cell and gene therapies for cancer. A concluding panel will highlight cross-cutting strategies to enhance immune responses, integrate therapeutic platforms, and accelerate progress in the field.

In addition to engaging with cutting-edge science, you'll build connections with experts and peers in an intimate environment designed to foster learning, collaboration, and meaningful connections.

The goals of this conference are to: 

• Highlight cutting-edge scientific and clinical advancements in oncolytic viruses, cell and immunotherapies, and combination approaches that leverage both platforms, with a core focus on challenges and topics of interest to academic researchers in basic science
• Explore strategies to overcome key barriers to the development and implementation of these therapies, such as tumor heterogeneity, off-target effects, delivery limitations, and interactions with the tumor microenvironment
• Foster knowledge exchange, collaboration, and networking through scientific presentations, abstracts/poster sessions, and informal discussions

Learning Objectives:
After participating in this conference, learners will be able to: 

• Describe emerging technologies driving innovation in oncolytic viruses, cell therapies, and combinatorial approaches that leverage both platforms
• Discuss the mechanisms of action and therapeutic potential of oncolytic viruses and cell therapies
• Identify strategies for overcoming key barriers to therapeutic efficacy for cell and gene therapies in cancer, such as tumor heterogeneity, off-target effects, delivery limitations, and interactions with the tumor microenvironment
• Recognize opportunities to integrate viral and cellular platforms to enhance immune responses and improve therapeutic outcomes
• Discuss emerging trends and unanswered questions driving future research in oncolytic viruses, cell therapies, and their combinatorial use in cancer treatment.

30 Days of On-Demand Access (beginning 48 hours after the event)